Feasibility of Iodine-131 6β-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case Series

References

• Mulatero P, Stowasser M, Loh K-C, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045–1050. 10.1210/jc.2003-031337
   PubMed Web of Science ®Google Scholar
• Douma S, Petidis K, Doumas M, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371: 1921–1926. 10.1016/S0140-6736(08)60834-X
   PubMed Web of Science ®Google Scholar
• Sica DA Endocrine causes of secondary hypertension. J Clin Hypertens 2008; 10: 534–540 10.1111/j.1751-7176.2008.08097.x
   Web of Science ®Google Scholar
• Thomas RM, Ruel E, Shantavasinkul PC, et al. Endocrine hypertension: an overview on the current etiopathogenesis and management options. World J Hypertens 2015; 5: 14–27. 10.5494/wjh.v5.i2.14
   PubMedGoogle Scholar
• Chou CH, Chen YH, Hung CS, et al. Aldosterone impairs vascular smooth muscle function: from clinical to bench research. J Clin Endocrinol Metab 2015; 100: 4339–4347. 10.1210/jc.2015-2752
   PubMed Web of Science ®Google Scholar
• Sawka AM, Young WF Jr, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 2001; 135: 258–261. 10.7326/0003-4819-135-4-200108210-00010
   PubMed Web of Science ®Google Scholar
• Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 1889–1916. 10.1210/jc.2015-4061
   PubMed Web of Science ®Google Scholar
• Magill SB, Raff H, Shaker JL, et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001; 86: 1066–1071. 10.1210/jcem.86.3.7282
   PubMed Web of Science ®Google Scholar
• Kempers MJ, Lenders JW, van Outheusden L, et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med 2009; 151: 329–337. 10.7326/0003-4819-151-5-200909010-00007
   PubMed Web of Science ®Google Scholar
• Stewart PM, Allolio B Adrenal vein sampling for Primary Aldosteronism: time for a reality check. Clin Endocrinol 2010; 72: 146–148. 10.1111/j.1365-2265.2009.03714.x
   PubMed Web of Science ®Google Scholar
• Sarkar SD, Beierwaltes H, Ice RD, et al. A new and superior adrenal scanning agent, NP-59. J Nucl Med 1975; 16: 1038–1042.
   PubMed Web of Science ®Google Scholar
• Sarkar SD, Cohen EL, Beierwaltes WH, et al. A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans. J Clin Endocrinol Metab 1977; 45: 353–362. 10.1210/jcem-45-2-353
   PubMed Web of Science ®Google Scholar
• Young WF Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol 2007; 66: 607–618. 10.1111/j.1365-2265.2007.02775.x
   PubMed Web of Science ®Google Scholar
• Tiu S-C, Choi C-H, Shek -C-C, et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005; 90: 72–78. 10.1210/jc.2004-1149
   PubMed Web of Science ®Google Scholar
• Rossi GP, Barisa M, Allolio B, et al. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab 2012; 97: 1606–1614. 10.1210/jc.2011-2830
   PubMed Web of Science ®Google Scholar
• Avram AM, Fig LM, Gross MD, Adrenal gland scintigraphy. Semin Nucl Med 2006; 36: 212–227. 10.1053/j.semnuclmed.2006.03.004
   PubMed Web of Science ®Google Scholar
• Williams TA, Lenders JW, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 2017; 5: 689–699. 10.1016/S2213-8587(17)30135-3
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Omura M, Satoh F, et al. Guidelines for the diagnosis and treatment of primary aldosteronism-The Japan Endocrine Society 2009. Endocrine 2011; 58: 711–721. 10.1507/endocrj.EJ11-0133
   Web of Science ®Google Scholar
• Lee JM, Kim MK, Ko SH, et al. Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab 2017; 32: 200–218. 10.3803/EnM.2017.32.2.200
   Web of Science ®Google Scholar
• Yen RF, Wu VC, Liu KL, et al. 131I-6β-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results. J Nucl Med 2009; 50: 1631–1637. 10.2967/jnumed.109.064873
   PubMed Web of Science ®Google Scholar
• Marcello DM, García SI, Muñoz JL, et al. NP-59 test for preoperative localization of primary hyperaldosteronism. Langenbecks Arch Surg 2017;402(2):303–308. 10.1007/s00423-017-1561-1
   PubMed Web of Science ®Google Scholar
• Nomura K, Kusakabe K, Maki M, et al. Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity. J Clin Endocrinol Metab 1990; 71: 825–830. 10.1210/jcem-71-4-825
   PubMed Web of Science ®Google Scholar
• Gross M, Valk T, Swanson D, et al. The role of pharmacologic manipulation in adrenal cortical scintigraphy. Semin Nucl MEd 1981, pp.128–148.
   PubMed Web of Science ®Google Scholar
• Cava GL, Imperiale A, Olianti C, et al. Spect semiquantitative analysis of adrenocortical 131i-6b-iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma. J Nucl Med 2003; 44: 1057–1064.
   PubMed Web of Science ®Google Scholar
• Wu MH, Liu FH, Lin KJ, et al. Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan. Nucl Med Commun. 2019;40:568–575. 10.1097/MNM.0000000000000987
   PubMed Web of Science ®Google Scholar
• Chen YC, Su YC, Wei CK, et al. Diagnostic value of I-131 NP-59 SPECT/CT scintigraphy in patients with subclinical or atypical features of primary aldosteronism. J Biomed Biotechnol. 2011;2011:209787. 10.1155/2011/209787
   PubMedGoogle Scholar
• Wong KK, Komissarova M, Avram AM, et al. Adrenal cortical imaging with I-131 NP-59 SPECT-CT. Clin Nucl Med 2010; 35: 865–869. 10.1097/RLU.0b013e3181f4a16d
   PubMed Web of Science ®Google Scholar
• Sasamura H, Hashimoto S, Kuribayashi S, et al. Use of gadolinium contrast adrenal venography for the assessment of primary aldosteronism in a patient with iodine allergy. Endocrine 2004; 51: 487–492. 10.1507/endocrj.51.487
   Web of Science ®Google Scholar
• Miller BS The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. Surgery 2010; 147: 174–175.
   PubMed Web of Science ®Google Scholar
• Chan H, Cheng L Use of NP-59 (131I-iodocholesterol) scan as a potential alternative to adrenal venous sampling in the investigation of primary aldosteronism: a 5-year retrospective study. Hong Kong J Radiol 2014; 17: 176–181 10.12809/hkjr1414230
   Google Scholar